This compound is a quinazoline derivative used as a pharmaceutical intermediate in the manufacturing process of erlotinib.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 179688-29-0
Potassium 2-((difluoromethyl)thio)acetate
pharmaceutical intermediate
Acyclovir Impurity K
pharmaceutical intermediate
Acyclovir Impurity I
pharmaceutical intermediate
4-Iodophenylacetic acid
pharmaceutical intermediate
6,7-Dimethoxy-3,4-dihydroquinazoline-4-one
pharmaceutical intermediate
3,4-Dihydro-7-methoxy-4-oxoquinazolin-6-yl acetate
pharmaceutical intermediate
8-Bromo-6-methyl-4(1H)-quinazolinone
pharmaceutical intermediate
7-Fluoro-6-nitro-4-hydroxyquinazoline
pharmaceutical intermediate
6,7-bis(2-methoxyethoxy)-3H-quinazolin-4-one
PMQWTUWLIGJTQD-UHFFFAOYSA-N
COCCOC1=C(C=C2C(=C1)C(=O)NC=N2)OCCOC